<!DOCTYPE html>
<meta charset="utf8" />
<html>
<script src="https://cdnjs.cloudflare.com/ajax/libs/jsdiff/5.2.0/diff.min.js"></script>
<link
  rel="stylesheet"
  href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css"
/>
<body>
    <header><h1>QuiVoteQuoi?</h1></header>
    <main>
        <section>
            <a href="/">⟵ Retourner à la recherche</a>
            <h2>Resolution on Commission Implementing Regulation (EU) 2021/1449 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron</h2>
            
            <ul>
                
                <li><a href="/vote/135953">Objection en vertu de l’article 112, paragraphes 2 et 3, du règlement intérieur: substances actives, dont le chlorotoluron et le difénoconazole - Objection pursuant to Rule 112(2) and (3): Active substances, including chlorotoluron and difenoconazole - Einwand gemäß Artikel 112 Absätze 2 und 3 GO: Wirkstoffe, einschließlich Chlortoluron und Difenoconazol - B9-0481/2021 - Proposition de résolution (ensemble du texte)</a></li>
                
            </ul>
        </section>
    </main>
</body>
</html>